Published in

Wiley, Journal of Leukocyte Biology, 3(112), p. 499-512, 2022

DOI: 10.1002/jlb.4a1221-770r

Links

Tools

Export citation

Search in Google Scholar

Alveolar macrophage-derived NRP2 curtails lung injury while boosting host defense in bacterial pneumonia

Journal article published in 2022 by Bing Wang ORCID, Wei Guo, Chen Qiu, Yunyan Sun, Chunxiao Zhao, Caihong Wu, Xun Lai, Xiaoming Feng
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Clearance of airway intruders by immune cells is required to resolve infectious pneumonia. However, the molecular mechanisms underlying this process remain elusive. Here, we demonstrated that alveolar macrophage (AM)-derived neuropilin 2 (NRP2) plays an essential role in controlling severe pneumonia by enhancing microbial clearance. Mice with conditional deletion of the NRP2 gene in AM had persistent bacteria, uncontrolled neutrophil influx, and decreased survival during Escherichia coli-induced pneumonia. In vitro assays demonstrated that NRP2 could bind to CD11b+Ly6Glo/+ neutrophils and promote their capacities in phagocytosis and killing of bacteria, which is partially contributed to the increased expression of TLR4 and TNF-a. These findings collectively revealed that AM-derived NRP2 protects the lungs from unwanted injury by promoting the clearance of invading pathogens. This study might provide a promising diagnostic biomarker and therapeutic target for severe pneumonia.